Loading...
Bionano Genomics, Inc.
BNGO•NASDAQ
Healthcare
Medical - Diagnostics & Research
$3.28
$-0.18(-5.08%)
Bionano Genomics, Inc. (BNGO) Financial Performance & Income Statement Overview
Review Bionano Genomics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-14.79%
↓ 14.79%
Operating Income Growth
51.69%
↑ 51.69%
Net Income Growth
51.82%
↑ 51.82%
Operating Cash Flow Growth
44.94%
↑ 44.94%
Operating Margin
-285.71%
↓ 285.71%
Gross Margin
3.37%
↑ 3.37%
Net Profit Margin
-294.05%
↓ 294.05%
ROE
-157.35%
↓ 157.35%
ROIC
-156.38%
↓ 156.38%
Bionano Genomics, Inc. (BNGO) Income Statement & Financial Overview
Review Bionano Genomics, Inc.'s (BNGO) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $8.16M | $6.07M | $7.77M | $8.77M |
Cost of Revenue | $4.75M | $14.52M | $5.19M | $5.95M |
Gross Profit | $3.42M | -$8.45M | $2.58M | $2.82M |
Gross Profit Ratio | $0.42 | -$1.39 | $0.33 | $0.32 |
R&D Expenses | $3.47M | $4.72M | $6.83M | $9.78M |
SG&A Expenses | $11.75M | $9.46M | $11.56M | $20.18M |
Operating Expenses | $15.36M | $35.45M | $19.60M | $29.95M |
Total Costs & Expenses | $20.10M | $49.97M | $24.79M | $35.90M |
Interest Income | $225000.00 | $376000.00 | $457000.00 | $1.04M |
Interest Expense | $27000.00 | $68000.00 | $0.00 | $122000.00 |
Depreciation & Amortization | $2.45M | $0.00 | $3.04M | $3.06M |
EBITDA | -$17.65M | -$43.90M | -$12.71M | -$28.26M |
EBITDA Ratio | -$2.16 | -$7.23 | -$1.64 | -$3.22 |
Operating Income | -$11.94M | -$43.90M | -$17.02M | -$27.13M |
Operating Income Ratio | -$1.46 | -$7.23 | -$2.19 | -$3.09 |
Other Income/Expenses (Net) | -$8.18M | -$321000.00 | $820000.00 | -$317000.00 |
Income Before Tax | -$20.12M | -$44.22M | -$16.20M | -$31.44M |
Income Before Tax Ratio | -$2.47 | -$7.28 | -$2.08 | -$3.59 |
Income Tax Expense | $1000.00 | $24000.00 | $26000.00 | -$18000.00 |
Net Income | -$20.13M | -$44.25M | -$16.22M | -$31.42M |
Net Income Ratio | -$2.47 | -$7.29 | -$2.09 | -$3.58 |
EPS | -$10.79 | -$30.92 | -$14.40 | -$35.75 |
Diluted EPS | -$10.79 | -$30.92 | -$14.40 | -$36.00 |
Weighted Avg Shares Outstanding | $1.87M | $1.43M | $1.13M | $872835.00 |
Weighted Avg Shares Outstanding (Diluted) | $1.87M | $1.43M | $1.13M | $878985.00 |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan